IMNN: Imunon, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12.50
Enterprise Value ($M) 2.18
Book Value ($M) 8.19
Book Value / Share 0.56
Price / Book 1.53
NCAV ($M) 6.33
NCAV / Share 0.44
Price / NCAV 1.97

Profitability (mra)
Return on Invested Capital (ROIC) -2.06
Return on Assets (ROA) -0.89
Return on Equity (ROE) -1.45

Liquidity (mrq)
Quick Ratio 2.30
Current Ratio 2.30

Balance Sheet (mrq) ($M)
Current Assets 12.53
Assets 14.39
Liabilities 6.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A CVI Investments, Inc. 4.90 -37.57

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 39,307 149,041 26.37
2025-02-03 44,623 97,228 45.90
2025-01-31 14,815 58,363 25.38
2025-01-30 7,968 30,424 26.19

(click for more detail)

Similar Companies
IMCC – IM Cannabis Corp. IMMX – Immix Biopharma, Inc.
IMNM – Immunome, Inc. IMTX – Immatics N.V.
INDP – Indaptus Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io